Literature DB >> 26456744

Quality of Life Assessment in Spina Bifida for Children (QUALAS-C): Development and Validation of a Novel Health-related Quality of Life Instrument.

Konrad M Szymanski1, Rosalia Misseri2, Benjamin Whittam2, David Y Yang2, Sonia-Maria Raposo2, Shelly J King2, Martin Kaefer2, Richard C Rink2, Mark P Cain2.   

Abstract

OBJECTIVE: To develop and validate a self-reported health-related QUAlity of Life Assessment in Spina bifida for Children (QUALAS-C).
METHODS: We drafted a 27-question pilot instrument using a patient-centered comprehensive item generation and refinement process. It was administered to a sample of children 8-12 years old with spina bifida (SB) recruited online via social media and in person at an outpatient SB clinic (January 2013-September 2014). Healthy controls were recruited at routine pediatrician visits. Validation and final questions were determined based on clinical relevance, high loadings on factor analysis, and domain psychometrics. Children with SB also completed the validated generic Kidscreen-27 instrument.
RESULTS: Median age of 150 participants was 9.6 years (60.7% male, 72.7% Caucasian), similar to 46 controls (P ≥ .10). There were 97 online and 53 clinic participants (89.0% and 84.2% of eligible, respectively). Face and content validities of the 2-domain, 10-question QUALAS-C were established by patients, parents, and experts. Internal consistency and test-retest reliability was high for the Esteem & Independence and Bladder & Bowel domains (Cronbach's alpha: 0.72-0.76, ICC: 0.74-0.77). Correlations between QUALAS-C domains were low (r = 0.51), indicating that QUALAS-C can differentiate between two distinct health-related quality of life components. Correlations between QUALAS-C and Kidscreen-27 were also low (r ≤ 0.44). QUALAS-C scores were significantly lower in children with SB than without (P < .0001).
CONCLUSION: QUALAS-C is a short, valid health-related quality of life tool for children with SB. It will be useful in clinical and research settings.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26456744     DOI: 10.1016/j.urology.2015.09.027

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Bladder Reconstruction Rates Differ among Centers Participating in National Spina Bifida Patient Registry.

Authors:  Jonathan C Routh; David B Joseph; Tiebin Liu; Michael S Schechter; Judy K Thibadeau; M Chad Wallis; Elisabeth A Ward; John S Wiener
Journal:  J Urol       Date:  2017-08-19       Impact factor: 7.450

2.  Parental Distress and Stress in Association with Health-Related Quality of Life in Youth with Spina Bifida: A Longitudinal Study.

Authors:  Colleen F Bechtel Driscoll; Joanna Buscemi; Grayson N Holmbeck
Journal:  J Dev Behav Pediatr       Date:  2018-12       Impact factor: 2.225

Review 3.  The Use of Social Media in Pediatric Urology-Forging New Paths or Crossing Boundaries?

Authors:  Hong Truong; Andrew Salib; Courtney K Rowe
Journal:  Curr Urol Rep       Date:  2019-10-16       Impact factor: 3.092

Review 4.  Spina Bifida: Pathogenesis, Mechanisms, and Genes in Mice and Humans.

Authors:  Siti W Mohd-Zin; Ahmed I Marwan; Mohamad K Abou Chaar; Azlina Ahmad-Annuar; Noraishah M Abdul-Aziz
Journal:  Scientifica (Cairo)       Date:  2017-02-13

Review 5.  The Management of the Pediatric Neurogenic Bladder.

Authors:  Renea M Sturm; Earl Y Cheng
Journal:  Curr Bladder Dysfunct Rep       Date:  2016-07-02

6.  TRANSLATION AND VALIDATION OF THE BRAZILIAN VERSION OF THE "QUALITY OF LIFE ASSESSMENT IN SPINA BIFIDA" QUESTIONNAIRE FOR CHILDREN AND TEENAGERS.

Authors:  Jorge Pompermaier; Maria Cristina de Andrade; Marcela Leal da Cruz; Antonio Macedo Júnior
Journal:  Rev Paul Pediatr       Date:  2020-08-28

7.  Validation of QUALAS-T, a health-related quality of life instrument for teenagers with spina bifida.

Authors:  Konrad M Szymański; Rosalia Misseri; Benjamin Whittam; Jessica T Casey; David Y Yang; Sonia-Maria Raposo; Shelly J King; Martin Kaefer; Richard C Rink; Mark P Cain
Journal:  Cent European J Urol       Date:  2017-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.